Urinary metabolomics of phenolic compounds reveals biomarkers of type-2 diabetes within the PREDIMED trial.
Domínguez-López I, Lozano-Castellón J, Vallverdú-Queralt A, Jáuregui O, Martínez-González MÁ, Hu FB, Fitó M, Ros E, Estruch R, Lamuela-Raventós RM.
Domínguez-López I, et al. Among authors: lozano castellon j.
Biomed Pharmacother. 2023 Jun;162:114703. doi: 10.1016/j.biopha.2023.114703. Epub 2023 Apr 14.
Biomed Pharmacother. 2023.
PMID: 37062219
Free article.
Clinical Trial.